Results 111 to 120 of about 26,095 (135)

Medication Adherence and Antithrombotic Therapy Outcomes: Insights From a Post Hoc Analysis of the AFIRE Trial. [PDF]

JACC Asia
Chiba N, Noda T, Nochioka K, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Matsui K, Ogawa H, Yasuda S, AFIRE Investigators.   +14 more
europepmc   +1 more source

Stroke and Bleeding Risks With Non-Vitamin K Oral Anticoagulants in Nonvalvular Atrial Fibrillation.

JAMA Netw Open
Bradley MC, Simon AL, Kolonoski J, Graham DJ, Zhang R, Connolly JG.   +5 more
europepmc   +1 more source

Efficacy and safety evaluation of thromboprophylaxis strategies for central venous catheter-related thrombosis in cancer patients: a bayesian network meta-analysis and bibliometric analysis. [PDF]

Front Pharmacol
Meng M, Xu Q, Qin S, Chen X, Qin C, Shen M, Xu D, Pang S, Zhong J, Fan Y, Xu Y, Yi Q, Su H, Qin J.   +13 more
europepmc   +1 more source

Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in Europe. [PDF]

J Comp Eff Res
Brodin E, Young A, Langer F, Alikhan R, Timo L, Lambrelli D, Nordstrom B, Booth A, Graham S, Mokgokong R, Jenkins A, Chaves J, Dai F, Subash R, Lehne M, Ghiani M, Mevius A, Fliegner D, Gottsäter A.   +18 more
europepmc   +1 more source

Comparative risk of nonvertebral fractures associated with oral anticoagulants in patients with venous thromboembolism. [PDF]

Am J Epidemiol
Zeng Z, Bea S, Sreedhara SK, Bykov K.
europepmc   +1 more source

Comparative safety of oral anticoagulants in severe renal impairment. [PDF]

Res Pract Thromb Haemost
Byrne R, Roberts LN.
europepmc   +1 more source

Comparative Effectiveness of Oral Anticoagulants and Home Time After Venous Thromboembolism in Frail and Non-Frail Older Adults. [PDF]

Am J Hematol
Park CM, Shi S, Chen X, Parks AL, Kim DH.   +4 more
europepmc   +1 more source

Population pharmacokinetics of rivaroxaban after transjugular intrahepatic portosystemic shunt. [PDF]

Eur J Clin Pharmacol
Jia M, Chai Y, Gao Y, Jing C, Zhu K, Zhu T, Wang L, Sun A, Yang J, Zhu Y, Feng Y, Cao Y, Li J.   +12 more
europepmc   +1 more source

The impact of body composition variability on coagulation monitoring in patients on direct oral factor Xa inhibitors for treatment of venous thromboembolism. [PDF]

Front Cardiovasc Med
Kurzmann-Guetl K, Leitner DR, Gary T, Avian A, Beck A, Rabensteiner J, Prueller F, Raggam RB, Brodmann M, Toplak H.   +9 more
europepmc   +1 more source